These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28288476)

  • 1. The Role of Rho/Rho-Kinase Pathway in the Pathogenesis of Cholesteatoma.
    Yeşilova M; Görür K; Ismi O; Özcan C; Büyükafşar K
    Otol Neurotol; 2017 Apr; 38(4):516-520. PubMed ID: 28288476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
    Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
    Wang H; Xu Z; Tang A; Su J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
    Liu Y; Cui Y; Yu L; Zhang P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
    Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
    Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
    Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hypoxia inducible factor 1 alpha and Von Hippel Lindau protein in human middle ear cholesteatoma.
    Adunka O; Gstoettner W; Knecht R; Kierner AC
    Laryngoscope; 2003 Jul; 113(7):1210-5. PubMed ID: 12838021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External auditory canal cholesteatoma: a rare complication of tympanoplasty.
    Viswanatha B
    Ear Nose Throat J; 2009 Nov; 88(11):1206-9. PubMed ID: 19924662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
    Park M; Lee B; Lee J
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
    Chung JW; Yoon TH
    Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of S100A1 in external auditory canal cholesteatoma.
    Naim R; Hormann K
    Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.